Citation, commencement and extent

1.-(1) These Regulations may be cited as the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2015 and come into force on 11th March 2015.

(2) These Regulations extend to England and Wales and Scotland.

Amendment of the Misuse of Drugs Regulations 2001

2.  The Misuse of Drugs Regulations 2001(2) are amended as follows.

3.  In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16 , 18, 19, 20, 23, 26 and 27)-

(a)after "4-Bromo-2,5-dimethoxy-a-methylphenethylamine" insert-

"1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)";

(b)after "4-Methyl-aminorex" insert-

"4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR)".

EXPLANATORY NOTE

(This note is not part of the Regulations)

These Regulations amend the Misuse of Drugs Regulations 2001 ("the Regulations"). The schedule of the Regulations in which a controlled drug is placed primarily affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed and dictates the record keeping, labelling and destruction requirements in relation to that drug. The controlled drugs placed in Schedule 1 to the Regulations are those subject to the tightest controls.

Regulation 3 adds a potent opoid known as MT-45 and a synthetic stimulant known as 4,4'-DMAR to Schedule 1 to the Regulations.

A full impact assessment of the effect that this instrument will have on the costs of business and the voluntary sector is available and is published with the Explanatory Memorandum alongside the instrument on www.legislation.gov.uk.